<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03734484</url>
  </required_header>
  <id_info>
    <org_study_id>01072019</org_study_id>
    <nct_id>NCT03734484</nct_id>
  </id_info>
  <brief_title>Gram Type Infection-Specific Sepsis Identification Using Machine Learning</brief_title>
  <official_title>Gram Type Infection-Specific Sepsis Identification Using Machine Learning</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dascena</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Dascena</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The focus of this study will be to conduct a prospective, randomized controlled trial (RCT)
      at Cape Regional Medical Center (CRMC), Oroville Hospital (OH), and UCSF Medical Center
      (UCSF) in which a Gram type infection-specific algorithm will be applied to EHR data for the
      detection of severe sepsis. For patients determined to have a high risk of severe sepsis, the
      algorithm will generate automated voice, telephone notification to nursing staff at CRMC, OH,
      and UCSF. The algorithm's performance will be measured by analysis of the primary endpoint,
      time to antibiotic administration. The secondary endpoint will be reduction in the
      administration of unnecessary antibiotics, which includes reductions in secondary antibiotics
      and reductions in total time on antibiotics.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 1, 2022</start_date>
  <completion_date type="Anticipated">March 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">November 30, 2022</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in time to antibiotic administration</measure>
    <time_frame>Through study completion, an average of 8 months</time_frame>
    <description>Change in time period between diagnosis of Gram infection and administration of antibiotics to treat infection</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in administration of unnecessary antibiotics</measure>
    <time_frame>Through study completion, an average of 8 months</time_frame>
    <description>Changes in amount of secondary antibiotics administered</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in administration of unnecessary antibiotics</measure>
    <time_frame>Through study completion, an average of 8 months</time_frame>
    <description>Changes in total hours spent on antibiotics</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">51645</enrollment>
  <condition>Sepsis</condition>
  <condition>Severe Sepsis</condition>
  <condition>Septic Shock</condition>
  <arm_group>
    <arm_group_label>Gram type infection-specific algorithm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The experimental arm will involve patients monitored by the Gram type infection-customized version of InSight.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard treatment protocol</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>The control arm will involve patients treated with the regular diagnosis and treatment protocol for gram-type infection, where fluid cultures are run to determine infection type.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>InSight</intervention_name>
    <description>The InSight algorithm which draws information from a patient's electronic health record (EHR) to predict the onset of severe sepsis, and in this study will be customized to differentiate between various Gram-type infections.</description>
    <arm_group_label>Gram type infection-specific algorithm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All adults above age 18 who are a member of one of the three subpopulations studied in
             this trial (patients with Gram-positive infection, patients with Gram-negative
             infection, and patients with mixed Gram-positive and Gram-negative infection) are
             eligible to participate in the study.

        Exclusion Criteria:

          -  Under age 18

          -  No record of Gram infection
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ritankar Das, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dascena</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ritankar Das, MSc</last_name>
    <phone>872-228-5332</phone>
    <email>ritankar@dascena.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Chris Barton, MD</last_name>
    <phone>415-206-5762</phone>
    <email>Chris.Barton@ucsf.edu</email>
  </overall_contact_backup>
  <reference>
    <citation>Calvert J, Mao Q, Hoffman JL, Jay M, Desautels T, Mohamadlou H, Chettipally U, Das R. Using electronic health record collected clinical variables to predict medical intensive care unit mortality. Ann Med Surg (Lond). 2016 Sep 6;11:52-57. eCollection 2016 Nov.</citation>
    <PMID>27699003</PMID>
  </reference>
  <reference>
    <citation>Shimabukuro DW, Barton CW, Feldman MD, Mataraso SJ, Das R. Effect of a machine learning-based severe sepsis prediction algorithm on patient survival and hospital length of stay: a randomised clinical trial. BMJ Open Respir Res. 2017 Nov 9;4(1):e000234. doi: 10.1136/bmjresp-2017-000234. eCollection 2017.</citation>
    <PMID>29435343</PMID>
  </reference>
  <reference>
    <citation>Mao Q, Jay M, Hoffman JL, Calvert J, Barton C, Shimabukuro D, Shieh L, Chettipally U, Fletcher G, Kerem Y, Zhou Y, Das R. Multicentre validation of a sepsis prediction algorithm using only vital sign data in the emergency department, general ward and ICU. BMJ Open. 2018 Jan 26;8(1):e017833. doi: 10.1136/bmjopen-2017-017833.</citation>
    <PMID>29374661</PMID>
  </reference>
  <verification_date>November 2018</verification_date>
  <study_first_submitted>November 1, 2018</study_first_submitted>
  <study_first_submitted_qc>November 6, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 8, 2018</study_first_posted>
  <last_update_submitted>November 6, 2018</last_update_submitted>
  <last_update_submitted_qc>November 6, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">November 8, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Dascena</keyword>
  <keyword>Gram infection</keyword>
  <keyword>antibiotic administration</keyword>
  <keyword>machine learning</keyword>
  <keyword>algorithm</keyword>
  <keyword>diagnostic</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Toxemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

